Systemic Amyloidosis due to Monoclonal Immunoglobulins, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 34-6 - October 27, 2020
- Imprint: Elsevier
- Editor: Raymond L. Comenzo
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 7 9 1 6 5 - 6
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 7 9 1 6 6 - 3
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six… Read more
Purchase options
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: The Spectrum of Monoclonal Immunoglobulin Diseases, Systemic Amyloidosis due to Clonal Plasma Cell Diseases, Systemic Amyloidosis due to Low-grade Lymphomas, The Process of Amyloid Formation due to Monoclonal Immunoglobulins, Cardiac Involvement, Renal Involvement, Liver and Gastrointestinal Involvement, Peripheral Nervous System Involvement, Options for Chemotherapy, Stem-cell Mobilization and Autologous Transplant, Monoclonal Antibody Therapies, Solid Organ Transplant, Supportive Care, Patient Voices, and Future Perspectives.
- Edition: 1
- Volume: 34-6
- Published: October 27, 2020
- Imprint: Elsevier
- Language: English
RC
Raymond L. Comenzo
Affiliations and expertise
By Raymond L. Comenzo, MD.,
Director, Transfusion Services
Director, John C. Davis Myeloma and Amyloid Program
Professor, Tufts University School of Medicine
Tufts Medical Center and Tufts University School of Medicine
Boston, MA, USA